{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-074628","form_type":"8-K","ticker":"COGT","cik":"0001622229","company_name":"Cogent Biosciences, Inc.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.843922+00:00","generated_at":"2026-06-04T09:03:58.997941+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cogent Biosciences exchanges 8.3M common shares for Series B non-voting convertible preferred","bullets":["8,300,000 common shares exchanged for 8,300 Series B Preferred convertible into 20,580,000 common shares.","Exchange closes March 25, 2024; Series B has no voting rights except on amendments to its preferences.","Post-exchange common outstanding: 95,613,396; Series A Preferred convertible into 18,616,250 common shares.","Issued under Section 3(a)(9) exemption; no registration required."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-074628","json":"https://secwatch.observer/filing/0001193125-24-074628.json","markdown":"https://secwatch.observer/filing/0001193125-24-074628.md","text":"https://secwatch.observer/filing/0001193125-24-074628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622229/000119312524074628/0001193125-24-074628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622229/000119312524074628/d796451d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:03:58.997941+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}